Normal view MARC view ISBD view

Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)

By:

Material type: Text

TextSubject(s):

Online resources:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Call number	URL	Status	Date due	Barcode
eBooks			Link to resource	Available

There are no comments on this title.

to post a comment.